Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of False-negative Findings of the Incomparable Accuracy and Swiftness of Flow Cytometric Diagnosis of Primary Central Nervous System Lymphoma.
Takeuchi H, Inaba T, Shishido-Hara Y, Tsukamoto T, Mizutani S, Okamoto T, Tanigawa S, Yamanaka T, Takahashi Y, Konishi E, Kuroda J, Hashimoto N. Takeuchi H, et al. Among authors: kuroda j. Neurol Med Chir (Tokyo). 2023 Nov 15;63(11):495-502. doi: 10.2176/jns-nmc.2023-0029. Epub 2023 Oct 18. Neurol Med Chir (Tokyo). 2023. PMID: 37853615 Free PMC article.
Cervical Local Cytokine Release Syndrome Following Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma.
Inoue Y, Fujino T, Chinen S, Niiyama-Uchibori Y, Ide D, Kawata M, Hashimoto K, Takimoto-Shimomura T, Nakayama A, Tsukamoto T, Mizutani S, Shimura Y, Hirano S, Kuroda J. Inoue Y, et al. Among authors: kuroda j. Cureus. 2023 May 11;15(5):e38905. doi: 10.7759/cureus.38905. eCollection 2023 May. Cureus. 2023. PMID: 37303362 Free PMC article.
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).
Ri M, Iida S, Saito K, Saito Y, Maruyama D, Asano A, Fukuhara S, Tsujimura H, Miyazaki K, Ota S, Fukuhara N, Negoro E, Kuroda J, Yoshida S, Ohtsuka E, Norifumi T, Tabayashi T, Takayama N, Saito T, Suzuki Y, Harada Y, Mizuno I, Yoshida I, Maruta M, Takamatsu Y, Katsuya H, Yoshimitsu M, Minami Y, Kanato K, Munakata W, Nagai H. Ri M, et al. Among authors: kuroda j. Cancer Chemother Pharmacol. 2025 Jan 24;95(1):29. doi: 10.1007/s00280-025-04752-1. Cancer Chemother Pharmacol. 2025. PMID: 39853402 Clinical Trial.
The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma.
Nagata H, Tsukamoto T, Kobayashi T, Takahashi R, Okano A, Uchiyama H, Kawata E, Uoshima N, Kaneko H, Fuchida SI, Nishiyama D, Nakao M, Fujino T, Mizutani S, Shimura Y, Kuroda J. Nagata H, et al. Among authors: kuroda j. Int J Clin Oncol. 2025 Jan 7. doi: 10.1007/s10147-025-02691-8. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39776016
Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort study.
Kanamori M, Tsuzuki S, Shibahara I, Saito K, Shimoda Y, Tanaka K, Yamaguchi S, Natsumeda M, Matsutani T, Hanihara M, Nakada M, Kuroda JI, Matsuda M, Yoshimoto K, Yonezawa U, Sonoda Y, Takano K, Yonezawa H, Otani Y, Nakahara Y, Uchida M, Nonaka M, Mineharu Y, Kitamura Y, Yamashita S, Yamauchi T, Miyake Y, Deguchi S, Beppu T, Tamura K, Koizumi S, Hirose Y, Asano K, Hiruta R, Kinoshita M, Miyake K, Nakayama N, Inoue A, Ono T, Sasaki T, Akiyama Y, Fukami S, Yoshino A, Kawanishi Y, Asanome T, Yamaguchi T, Takahashi M, Yamasaki F, Arakawa Y, Narita Y. Kanamori M, et al. Among authors: kuroda ji. Neurooncol Adv. 2024 Nov 28;6(1):vdae176. doi: 10.1093/noajnl/vdae176. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39659832 Free PMC article.
Role of versican in extracellular matrix formation: analysis in 3D culture.
Jahan N, Islam S, Sivasundaram K, Ota A, Naito M, Kuroda J, Watanabe H. Jahan N, et al. Among authors: kuroda j. Am J Physiol Cell Physiol. 2025 Jan 1;328(1):C245-C257. doi: 10.1152/ajpcell.00495.2024. Epub 2024 Dec 10. Am J Physiol Cell Physiol. 2025. PMID: 39656505
577 results